Global Chinese Drug Delivery Market
China Drug Delivery Market Research 2024 with Competitive Analysis of Gerresheimer, Pfizer, Shanghai Fosun Pharmaceutical, Hutchison China MediTech, GL Montrose, & Becton, Dickinson and Co
July 02, 2024 07:51 ET | Research and Markets
Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "China Drug Delivery Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The China drug delivery market is...
22157.jpg
Drug Development Online Course: Key to Success from Concept to Commercialization - Earn Up to 8 Credits Towards RAC Recertification Upon Full Completion
January 17, 2024 10:33 ET | Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Drug Development: Key to Success from Concept to Commercialization" training has been added to ResearchAndMarkets.com's offering.Join Top Drug...
22157.jpg
United States VVZ-149 Market Report 2022: A New Mechanism-Based Non-Narcotic and Non-NSAID Analgesic by Vivozon - Emerging Drug Insights and Market Forecasts to 2032
March 07, 2023 10:28 ET | Research and Markets
Dublin, March 07, 2023 (GLOBE NEWSWIRE) -- The "United States VVZ-149 Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
2 Day Virtual Drug Development and Regulatory Approval Process Course: Key to Success from Concept to Commercialization Course - July 7th-8th, 2022
June 14, 2022 06:18 ET | Research and Markets
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Drug Development: Key to Success from Concept to Commercialization Course" training has been added to ResearchAndMarkets.com's offering. The course...
22157.jpg
Two Day Virtual Drug Development Process Training Course: Key to Success from Concept to Commercialization (May 12-13, 2022)
April 20, 2022 04:53 ET | Research and Markets
Dublin, April 20, 2022 (GLOBE NEWSWIRE) -- The "Drug Development: Key to Success from Concept to Commercialization Course" training has been added to ResearchAndMarkets.com's offering. The course...